A polio outbreak response in Tigray with the novel oral polio vaccine type 2 (nOPV2) vaccine: used as an opportunity to enhance the routine immunization [WHO]
![](/images/joomgrabber/2024-06/70f65951da.jpeg)
Two rounds of polio vaccination campaigns were conducted using novel Oral Polio Vaccine type 2 (nOPV2) in Tigray region of Ethiopia to prevent transmission and circulation of variant polio viruses. Round one campaign was conducted from 23 - 28 April 2024 in 79 accessible woredas, while second round was from 10 - 15 June 2024 followed by a mop-up vaccination for two days.